SourceOne Stock Info  Your one source site for stock research

 

 

 

Company Website

Investor Relations

 

 

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

 

 

 

 

 

 

 

 

MedImmune, Inc.

 

MEDI

MedImmune, Inc. is a biotechnology company focusing its efforts on the areas of infectious disease, oncology and immunology. The company markets four products: Synagis (palivizumab) and FluMist (Influenza Virus Vaccine Live, Intranasal) to help prevent two common respiratory infectious diseases; Ethyol (amifostine) to help reduce undesired side effects of certain anti-cancer, chemo and radiotherapies, and Cytogam (cytomegalovirus immune globulin intravenous (human)) to help prevent cytomegalovirus (CMV) disease associated with solid organ transplantation. The company operates facilities in the United States and Europe to manufacture and distribute one or more components of each of its products. MedImmune also has clinical, research and development staff in the United States, by which it is developing a pipeline of product candidates for potential marketing.

 

Stock Quotes and Other Information

Nasdaq

NYSE

Msn

Yahoo

Silicon Investor

Excite

Lycos

Market Watch

Clear Station

StockHouse

 

SourceOne Message Board

 

Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name

 

 

 

 

 

 

 

 

 

 

 

 

 

S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35

 

Home